Oppenheimer & Co’s Vivani Medical VANI Stock Holding History

Oppenheimer & Co’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,671	Closed	-$73K	–	1575
2021 Q3	$73K	Buy	+7,671	New	+$86.4K	﹤0.01%	1460

Other funds holding VANI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Oppenheimer & Co's VANI Position: Q4 2021 in Review

Oppenheimer & Co sold out of Vivani Medical (VANI) in Q4 2021, closing a stake of 7,671 shares — an estimated $73K sold.

Oppenheimer & Co first reported a position in VANI in Q3 2021 and held it in 1 quarter. The position peaked at $73K in Q3 2021. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2021.

Oppenheimer & Co reported no remaining Vivani Medical position as of Q4 2021 after selling out during the quarter.
Oppenheimer & Co sold 7,671 Vivani Medical shares in Q4 2021, an estimated $73K.
Oppenheimer & Co first reported a position in Vivani Medical in Q3 2021 and held it in 1 quarter.
Oppenheimer & Co's Vivani Medical position peaked at $73K in Q3 2021.
30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.